Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 58569043 | 5856904 | 3 | F | 20050701 | 0 | 20050810 | 20120106 | DIR | 5.70 | YR | M | N | 25.60000 | KG | 20120105 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 58569043 | 5856904 | 1 | PS | TOPAMAX | 1 | ORAL | N | 20505 | 100 | MG | TABLET | ||||||||
| 58569043 | 5856904 | 2 | C | CARBATROL | 1 | ORAL | (300 MG DAILY IN MORNING AND 400 MG DAILY AT NIGHT) | 0 | 700 | MG | |||||||||
| 58569043 | 5856904 | 3 | C | KEPPRA | 1 | ORAL | 0 | 500 | MG | ||||||||||
| 58569043 | 5856904 | 4 | C | ABILIFY | 1 | ORAL | (1CC IN MORNING AND 2CC AT NIGHT) | 0 | 3 | ML | |||||||||
| 58569043 | 5856904 | 5 | C | DIASTAT | 1 | 0 | 10 | MG |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 58569043 | 5856904 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 58569043 | 5856904 | ASPIRATION | |
| 58569043 | 5856904 | EPISTAXIS | |
| 58569043 | 5856904 | SUDDEN DEATH |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |